NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

People with sickle cell disease are immunocompromised, which means they have an increased risk of infection. For this reason, immunizations are an important part of complete sickle cell care. This ...

The National Academies of Sciences, Engineering, and Medicine Committee on Sickle Cell Disease in Social Security Disability Evaluations is inviting people with sickle cell disease (SCD) and ...

Next review: More evidence on exagamglogene autotemcel is being collected. After this, NICE will decide whether to recommend it for use in the NHS and update the guidance. It will be available with ...

Sickle cell anemia is the most common form of severe hemoglobin disorder. An inherited disease, that is, passed on by the parents and present at birth, sickle cell anemia is also a chronic disease and ...

Unlike people with sickle cell disease, they carry only one gene for sickle cell, and one normal gene. The condition, which is diagnosed through a blood test, doesn’t usually affect their daily lives.

Copyright 2025 The Associated Press. All Rights Reserved. At least 29 recruits have died during basic training at law enforcement academies nationwide in the last ...

Please permit me a space to draw the attention of Guyanese to the seriousness of the pain and agony of Sickle Cell disease by sharing the experience of a close childhood friend. My friend got ...

was cleared by the FDA to treat small cell lung cancer (SCLC), the first cell engager therapy to be authorized for the disease. SCLC is a difficult-to-treat disease, and less than 3% of patients with ...